← Leaderboards
Yiping Yang
Duke University
$13,692,641
Attributed
$15,166,588
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$15,166,588 · 10
By mechanism
R01$10,154,709 · 5
U01$2,824,595 · 1
P01$924,731 · 1
R21$805,065 · 2
K22$457,488 · 1
Top collaborators
- Xiaopei Huang6 shared
Most similar at Duke University
Same institution · by research overlap
- John H Sampson$43,413,436
- Sudarshan K Rajagopal$6,060,418
- Thomas F Tedder$11,276,163
- John P Chute$16,426,438
- Duane A. Mitchell$34,257,734
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingDesignT-LymphocyteVaccinia VirusTumorTumor ImmunityPathway InteractionsIn VivoLigandsMalignant NeoplasmsCancer ImmunotherapyVaccinesBaseImmuneCd8b1 GeneLeadCytokineNovel StrategiesProductionSignal TransductionGenerationsImmune SystemImmunotherapeutic Agent
Grant awards (48)
Regulation of tumor-infiltrating T cells by macrophages$432,678
R01 · FY2023 · CA · contact PI
Role of macrophage polarization in multi-organ fibrosis of chronic GVHD$547,124
R01 · FY2022 · HL · contact PI
Regulation of tumor-infiltrating T cells by macrophages$432,678
R01 · FY2022 · CA · contact PI
Role of macrophage polarization in multi-organ fibrosis of chronic GVHD$547,124
R01 · FY2021 · HL · contact PI
Regulation of tumor-infiltrating T cells by macrophages$441,166
R01 · FY2021 · CA · contact PI
Role of macrophage polarization in multi-organ fibrosis of chronic GVHD$547,124
R01 · FY2020 · HL · contact PI
T Memory Stem Cells in Cancer$448,495
R01 · FY2020 · CA · contact PI
T memory stem cells in cancer$430,580
R01 · FY2019 · CA · contact PI
T memory stem cells in cancer$443,898
R01 · FY2018 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$308,693
R01 · FY2018 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$49,057
R01 · FY2018 · CA · contact PI
T memory stem cells in cancer$436,428
R01 · FY2017 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$357,750
R01 · FY2017 · CA · contact PI
T memory stem cells in cancer$421,488
R01 · FY2016 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$357,750
R01 · FY2016 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$357,376
R01 · FY2015 · CA · contact PI
Role of inflammation in cancer progression$172,913
R21 · FY2015 · CA · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$353,250
R01 · FY2014 · CA · contact PI
Role of inflammation in cancer progression$205,102
R21 · FY2014 · CA · contact PI
Mechanisms for NK Cell Activation in Vaccinia Virus Control$540,847
U01 · FY2013 · AI · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$295,150
R01 · FY2013 · CA · contact PI
Novel Vaccine Strategies in Stem Cell Transplantation$174,100
P01 · FY2013 · CA · contact PI
Mechanisms for NK Cell Activation in Vaccinia Virus Control$575,369
U01 · FY2012 · AI · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$313,989
R01 · FY2012 · CA · contact PI
Novel Vaccine Strategies in Stem Cell Transplantation$185,214
P01 · FY2012 · CA · contact PI
Mechanisms for NK Cell Activation in Vaccinia Virus Control$574,080
U01 · FY2011 · AI · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$313,989
R01 · FY2011 · CA · contact PI
Novel Vaccine Strategies in Stem Cell Transplantation$185,216
P01 · FY2011 · CA · contact PI
Mechanisms for NK Cell Activation in Vaccinia Virus Control$572,066
U01 · FY2010 · AI · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$323,700
R01 · FY2010 · CA · contact PI
TLR Signaling in CD8 T Cell Response to Vaccinia Virus$193,050
R21 · FY2010 · AI · contact PI
Novel Vaccine Strategies in Stem Cell Transplantation$190,952
P01 · FY2010 · CA · contact PI
Mechanisms for NK Cell Activation in Vaccinia Virus Control$562,233
U01 · FY2009 · AI · contact PI
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant$323,700
R01 · FY2009 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$288,390
R01 · FY2009 · CA · contact PI
TLR Signaling in CD8 T Cell Response to Vaccinia Virus$234,000
R21 · FY2009 · AI · contact PI
Novel Vaccine Strategies in Stem Cell Transplantation$189,249
P01 · FY2009 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$55,452
R01 · FY2009 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$288,390
R01 · FY2008 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$53,973
R01 · FY2008 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$288,390
R01 · FY2007 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$52,509
R01 · FY2007 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$297,003
R01 · FY2006 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$43,265
R01 · FY2006 · CA · contact PI
The Role of Toll-Like Receptors in Cancer Immunotherapy$304,150
R01 · FY2005 · CA
Immunotherapy for Epstein-Barr Virus-associated Malignan$152,496
K22 · FY2004 · CA
Immunotherapy for Epstein-Barr Virus-associated Malignan$152,496
K22 · FY2003 · CA
Immunotherapy for Epstein-Barr Virus-associated Malignan$152,496
K22 · FY2002 · CA